This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.
Patients accrued
Patients with multiple myeloma
Number of approved sites
M1000 Biobank participants
An MRDR paper investigating the presence of 1q21 gain and amplification on outcomes in Daratumumab-treated MM patients has now been published!
Read moreThe recording of the meeting is now available to those who may have missed out!
Read more
